# MusclePharm Corp

MusclePharm Corp is a company headquartered in Denver, CO, United States.

## Company overview

- **Legal name:** MusclePharm Corp
- **Former names in filing history:** Tone in Twenty (2007-11-02 to 2010-02-25)
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Denver, CO, United States
- **Incorporated in:** NV
- **Fiscal year end:** December 31
- **SEC CIK:** 0001415684

## About

MusclePharm Corp is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001415684, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2022-04-15, it reported annual revenue of USD 50,042,000; net income of USD -12,866,000; total assets of USD 11,210,000 for the fiscal period ended 2021-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2021 (period ended 2021-12-31)

- **Revenue:** $50.0M (USD 50,042,000)
- **Net income:** -$12.9M (USD -12,866,000)
- **Total assets:** $11.2M (USD 11,210,000)
- **Cash and equivalents:** $1.2M (USD 1,223,000)
- **Operating cash flow:** -$8.0M (USD -8,042,000)
- **Later filings:** Total assets: shown as originally filed; later filings report different values for the same periods.

### FY2020 (period ended 2020-12-31)

- **Revenue:** $64.4M (USD 64,440,000)
- **Net income:** $3.2M (USD 3,185,000)
- **Total assets:** $13.0M (USD 13,002,000)
- **Cash and equivalents:** $2.0M (USD 2,003,000)
- **Operating cash flow:** -$868,000 (USD -868,000)
- **Later filings:** Cash and equivalents: shown as originally filed; later filings report different values for the same periods.

### FY2019 (period ended 2019-12-31)

- **Revenue:** $79.7M (USD 79,667,000)
- **Net income:** -$18.9M (USD -18,927,000)
- **Total assets:** $14.5M (USD 14,540,000)

### FY2017 (period ended 2017-12-31)

- **Revenue:** $102.2M (USD 102,155,000)
- **Net income:** -$11.0M (USD -10,973,000)
- **Total assets:** $33.8M (USD 33,826,000)
- **Later filings:** Net income, Total assets: shown as originally filed; later filings report different values for the same periods.

## Recent SEC filings

- Form 8-K — filed 2023-08-31 — period 2023-08-22
- Form 8-K — filed 2023-07-19 — period 2023-07-10
- Form 8-K — filed 2023-03-10 — period 2023-03-09
- Form 8-K — filed 2023-01-11 — period 2023-01-09 — 8K
- Form 8-K — filed 2023-01-11 — period 2023-01-10 — 8K CHANGE IN REGISTRANT
- Form 8-K — filed 2023-01-09 — period 2023-01-09
- Form 8-K — filed 2022-09-29 — period 2022-09-26
- Form 8-K — filed 2022-09-19 — period 2022-08-26
- Form 8-K — filed 2022-08-23 — period 2022-08-17
- Form 8-K — filed 2022-08-22 — period 2022-08-22
- Form 8-K — filed 2022-07-28 — period 2022-07-22
- Form 8-K — filed 2022-07-12 — period 2022-07-07

---

Updated: 2026-10-23T20:12:17Z

Canonical page: https://altss.com/profile/musclepharm-corp

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology